Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Cleghorn, J.M.
1988.
A Neurodiagnostlc Approach to Schizophrenia.
The Canadian Journal of Psychiatry,
Vol. 33,
Issue. 6,
p.
555.
Waddington, John L.
1988.
The ageing brain, neuroleptic drugs and the enigma of schizophrenia.
Irish Journal of Medical Science,
Vol. 157,
Issue. 5,
p.
135.
McKenna, P. J.
Mortimer, A. M.
and
Lund, C. E.
1988.
The Motor Disorders of Severe Psychiatric Illness: a Conflict of Paradigms.
British Journal of Psychiatry,
Vol. 152,
Issue. 6,
p.
863.
Healy, D
1989.
Neuroleptics and Psychic Indifference: A Review.
Journal of the Royal Society of Medicine,
Vol. 82,
Issue. 10,
p.
615.
Waddington, John L.
1989.
Sight and Insight: Brain Dopamine Receptor Occupancy by Neuroleptics Visualised in Living Schizophrenic Patients by Positron Emission Tomography.
British Journal of Psychiatry,
Vol. 154,
Issue. 4,
p.
433.
Harrison, P. J.
and
Pearson, R. C. A.
1989.
Olfaction and Psychiatry.
British Journal of Psychiatry,
Vol. 155,
Issue. 6,
p.
822.
Reynolds, G. P.
1989.
Beyond the Dopamine Hypothesis.
British Journal of Psychiatry,
Vol. 155,
Issue. 3,
p.
305.
Schwarzkopf, Steven B.
Lamberti, J.Steven
Jiminez, Maureen
Kane, Catherine F.
Henricks, Michael
and
Nasrallah, Henry A.
1990.
Visual evoked potential correlates of positive/negative symptoms in schizophrenia.
Biological Psychiatry,
Vol. 27,
Issue. 4,
p.
400.
Cameron, Donald L.
and
Crocker, Ann D.
1990.
The hypothyroid rat as a model of increased sensitivity to dopamine receptor agonists.
Pharmacology Biochemistry and Behavior,
Vol. 37,
Issue. 4,
p.
627.
Wetzel, H.
and
Benkert, O.
1990.
Psychopharmaka heute.
p.
108.
White, David M.
Daniell, William E.
Maxwell, James K.
and
Townes, Brenda D.
1990.
Psychosis following styrene exposure: A case report of neuropsychological sequelae.
Journal of Clinical and Experimental Neuropsychology,
Vol. 12,
Issue. 5,
p.
798.
Healy, David
1990.
Schizophrenia: Basic, release, reactive and defect processes.
Human Psychopharmacology: Clinical and Experimental,
Vol. 5,
Issue. 2,
p.
105.
Cleghorn, J. M.
Garnett, E. S.
Nahmias, C.
Brown, G. M.
Kaplan, R. D.
Szechtman, H.
Szechtman, B.
Franco, S.
Dermer, S. W.
and
Cook, P.
1990.
Regional Brain Metabolism During Auditory Hallucinations in Chronic Schizophrenia.
British Journal of Psychiatry,
Vol. 157,
Issue. 4,
p.
562.
Frith, Chris
1991.
In what context is latent inhibition relevant to the symptoms of schizophrenia?.
Behavioral and Brain Sciences,
Vol. 14,
Issue. 1,
p.
28.
Oke, Arvin F.
and
Adams, Ralph N.
1991.
Is another loop needed to explain schizophrenia?.
Behavioral and Brain Sciences,
Vol. 14,
Issue. 1,
p.
39.
Swerdlow, Neal R.
1991.
Neuropsychology of schizophrenia: The “hole” thing is wrong.
Behavioral and Brain Sciences,
Vol. 14,
Issue. 1,
p.
51.
Crusio, Wim E.
1991.
The neuropsychology of schizophrenia: A perspective from neurobehavioral genetics.
Behavioral and Brain Sciences,
Vol. 14,
Issue. 1,
p.
23.
Venables, Peter H.
1991.
Positiwe and negatiwe symptoms, the hippocampus and P3.
Behavioral and Brain Sciences,
Vol. 14,
Issue. 1,
p.
53.
Gewirtz, Jonathan C.
1991.
Novelty value in associative learning.
Behavioral and Brain Sciences,
Vol. 14,
Issue. 1,
p.
29.
Hoffman, Ralph E.
1991.
The mechanism of positive symptoms in schizophrenia.
Behavioral and Brain Sciences,
Vol. 14,
Issue. 1,
p.
33.
eLetters
No eLetters have been published for this article.